[Targeted therapy in hematologic neoplasia: overview].
Tauchi
Tetsuzo
T
First Department of Internal Medicine, Tokyo Medical University.
Ohyashiki
Kazuma
K
D051231:Farnesyltranstransferase / Q000037:antagonists & inhibitors; D016044:Fusion Proteins, bcr-abl; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D051941:fms-Like Tyrosine Kinase 3 / Q000037:antagonists & inhibitors
D051231:Farnesyltranstransferase; C497970:FLT3 protein, human; D011505:Protein-Tyrosine Kinases; D051941:fms-Like Tyrosine Kinase 3; D016044:Fusion Proteins, bcr-abl